Skip to Content

BMS 6077 (Metaglip 2.5 mg / 500 mg)

Generic Name: glipizide/metformin

Pill with imprint BMS 6077 is White, Elliptical / Oval and has been identified as Metaglip 2.5 mg / 500 mg. It is supplied by Bristol-Myers Squibb.

Metaglip is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metaglip 2.5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 6077


Generic Name:
BMS 6077
2.5 mg / 500 mg
Elliptical / Oval
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bristol-Myers Squibb

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.